Abstract:Inflammation is the seventh hallmark of cancer. Growing evidence indicated inflammation was linked to the progression and prognosis of many malignancies. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), as two inflammation markers, reported frequently in the incidence and progress of solid cancers, but little research has concerned these markers in thyroid disease. In this study, the expression of ESR and CRP both in papillary thyroid carcinoma (PTC) and nodular goiter was investigated.512 patients were recruited to this study, including 341 PTC and 171 nodular goiters. Serum ESR and CRP were tested before operation. The clinical pathological factors such as gender, age, body mass index (BMI), tumor size, extrathyroidal extension, capsule invasion, lymphatic metastasis, distant metastasis, and other thyroid specific markers were subanalyzed in the PTC group.In patients with PTC, the mean level of ESR was 14.24 ± 11.35 mm/h, which was lower than patients with nodular goiter (16.90 ± 12.00 mm/h, p = 0.006). Meanwhile the mean level of CRP was 1.81 ± 3.51 mg/L in PTC, which was lower than patients with nodular goiter (2.09 ± 3.34 mg/L, p = 0.008). Subanalysis in PTC showed that the ESR/CRP level has no significant difference concerning the capsule invasion, extrathyroidal extension, T grades, lymphatic metastasis, distant metastasis, Tumor Nodulus Metastases (TNM) and tumor sizes (p > 0.05). Pearson's correlation analysis showed a positive correlation between ESR and CRP (r = 0.416, p = 0.000), ESR and Tg (r = 0.140, p = 0.002), CRP and Tg (r = 0.187, p = 0.000). The results of multivariate logistic analysis showed that gender and age were the independent risk factors of ESR, meanwhile age and BMI were the independent risk factors of CRP.The present study demonstrated a different expression of ESR and CRP between PTC and nodular goiter. Even though the difference in absolute figures between them was very small, it could help clinicians to distinguish the difference between nodular goiter and PTC to some extent. ESR/CRP may have potential value in distinguishing thyroid benign disease from malignant tumors. However, ESR and CRP had no effect on the progress of PTC. They may not have potential value currently in PTC staging and predicting prognosis.

Evaluation of the clinical and prognostic importance of infection parameters in thyroid cancers: A cross-sectional study

Association between blood inflammatory indicators and prognosis of papillary thyroid carcinoma: a narrative review

Evaluation of the correlation of neutrophil/lymphocyte ratio with prognostic classification systems in papillary thyroid carcinoma patients

The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size

Evaluation of Proinflammatory Cytokine and Neopterin Levels in Women with Papillary Thyroid Carcinoma

Comparison of the prognostic values of selected inflammation based scores in patients with medullary thyroid carcinoma: A pilot study.

Assessment of inflammatory parameters as predictive markers for malignancy in thyroid nodules: a study on the correlation with Bethesda classification

Relationship Between Serum Inflammatory Factor Levels and Differentiated Thyroid Carcinoma

Peripheral Blood Inflammatory Markers Can Predict Benign and Malignant Thyroid Nodules

Inflammation Markers Have Important Value in Predicting Relapse in Patients with papillary thyroid carcinoma: A Long-Term Follow-Up Retrospective Study

Comparison of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with thyroiditis and papillary tumors

Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer

Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter

Predictive values of the selected inflammatory index in elderly patients with papillary thyroid cancer

The Correlation Between Biological Markers and Prognosis in Thyroid Cancer

Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer

Prevalence of Thyroid Nodules and Predictive Factors for their Malignancy: Is there any Correlation between Level of TSH and Type of Malignancy?: A Cross Sectional Study

Association of the Preoperative Inflammation-Based Scores with TNM Stage and Recurrence in Patients with Papillary Thyroid Carcinoma: A Retrospective, Multicenter Analysis

A new risk factor indicator for papillary thyroid cancer based on immune infiltration

Systemic immune-inflammation index: A new marker in differentiation of different thyroid diseases

Prognostic Impact of Inflammatory Markers PLR, LMR, PDW, MPV in Medullary Thyroid Carcinoma